Satisfaction with Cancer Care – Core questionnaire

Gender Neutral
Type Standalone
Testing Phase IV - in development
Principal investigator(s)
Anne Brédart
Psycho-Oncology Unit, Institut Curie
Paris, France

Project summary

The EORTC Satisfaction with cancer care core questionnaire – EORTC PATSAT-C33 – is a comprehensive instrument aimed to assess the perception of quality of the care received in any hospital cancer care setting. The specific outpatient module – EORTC OUT-PATSAT7 – addresses the perception of quality of additional aspects of care specific to ambulatory cancer care settings.

The EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 are composed of 33 and 7 items, respectively. The core questionnaire encompasses three sections addressing doctors, nurses/radiotherapy technicians, and service and care organisation. The doctor section comprises three sub-domains addressing technical skills (3 items), information exchange (3 items), and affective behaviour (4 items). The nurses/radiotherapy technicians section encompasses two subdomains addressing information provision and responsiveness (3 items) and affective behaviour (4 items). The service and care organisation section comprises three sub-domains including coordination (4 items), interaction with health care team (7 items) and five single items. The specific outpatient satisfaction module includes a single item addressing continuity and two sub-domains addressing convenience (3 items) and another addressing transition (3 items).

The international phase IV field-testing study of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 is underway. The aim of the present study is to validate the EORTC PATSAT-C33 and OUT-PATSAT7 in a large international field study and to confirm the psychometric properties of its scales in cancer patients attending in- and out-patient cancer care hospital services. We will investigate the EORTC PATSAT-C33 and OUT-PATSAT7 for cross-cultural applicability and acceptability, scale structure, reliability including test-retest and internal consistency, validity, including construct (known-group comparisons), convergent and divergent validity, responsiveness to change and cross-cultural invariance of psychometric properties.

The EORTC PATSAT-C33 and OUT-PATSAT7 will be administered to four main groups of patients based on the cancer care settings which they attend, as outpatient: a) chemotherapy day clinic/consultation for oral treatment; b) ambulatory radiotherapy; c) consultation for follow-up surveillance to check for signs of recurrence; and as inpatients: d) an oncology or surgery ward. Patients will be asked to complete questionnaires at one moment during the treatment or remission phase of the disease trajectory. This assessment (T1) will be performed a) between 3 to 6 cycles of chemotherapy or after 2 cycles of other cancer treatment (e.g., biological therapy), b) 2 to 6 weeks of radiotherapy, c) after the 3rd to 24th month post-treatment, or d) 3 days after hospital discharge.

Patients will receive the EORTC QLQ-C30, EORTC PATSAT-C33, and the OUT-PATSAT7, as well as the Oberst’s perception of care scales, and items addressing their wish to recommend the hospital or to look for a second medical opinion. The sample size will be of 500 to ensure balanced patients’ representation across outpatient cancer care settings and cross-culturally. For the test-retest assessment (T2), we aim to include 125 patients for intra-class cluster correlation (ICC). Responsiveness to change will be tested with a third assessment (T3) on a sub-sample of ~ 260 patients.

Fourteen institutions from at four European regions and outside Europe are participating in the study since December June 2019 during around a 25-months data collection period.

If there were any researcher interested in participating to this study, please contact Anne Brédart: anne.bredart@curie.fr

Achievements

The preliminary development and pilot-testing of the EORTC PATSAT-C33 and OUT-PATSAT7 has been published in three peer-reviewed scientific journals. Phase IV psychometric study is underway.

64 patients have completed

Future plans

Achieving phase IV data collection

For patients

The EORTC Satisfaction with cancer care core questionnaire – EORTC PATSAT-C33 – is a comprehensive instrument aimed to assess the perception of quality of the care received in any hospital cancer care setting. The specific outpatient module – EORTC OUT-PATSAT7 – addresses the perception of quality of additional aspects of care specific to ambulatory cancer care settings.

Publications

Bredart, A., et al. (2018). “Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7).” European Journal of Cancer Care (English Language Edition) 27(1).

Bredart, A., et al. (2017). “The European organization for research and treatment of cancer – satisfaction with cancer care questionnaire: revision and extended application development.” Psycho-Oncology 26(3): 400-404.